{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T19:35:46Z","timestamp":1772998546775,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"the CNPq (Conselho Nacional de Desenvolvimento Cient\u00edfco e Tecnol\u00f3gico \u2013 National Council for Scientific and Technological Development"},{"DOI":"10.13039\/501100004586","name":"FAPERJ","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.seizure.2019.09.003","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T11:23:11Z","timestamp":1568028191000},"page":"318-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Association between high titers of glutamic acid decarboxylase antibody and epilepsy in patients with type 1 diabetes mellitus: A cross-sectional study"],"prefix":"10.1016","volume":"71","author":[{"given":"Tiago S.","family":"Aguiar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana R.","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora B.","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia Cec\u00edlia S.","family":"R\u00eago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenita","family":"Zajdenverg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gil Fernando","family":"Salles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soniza V.","family":"Alves-Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Rodacki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Antonio","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2019.09.003_bib0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2019.09.003_bib0010","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.09.003_bib0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","article-title":"Neurological autoantibody prevalence in epilepsy of unknown etiology","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2019.09.003_bib0020","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00125-016-4142-x","article-title":"Type 1 diabetes mellitus and risk of incident epilepsy: a population-based, open-cohort study","volume":"60","author":"Dafoulas","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.seizure.2019.09.003_bib0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2018.01.007","article-title":"Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: a comparison of anti-GAD antibody titers and time-dependent changes between neurologic disease and type I diabetes mellitus","volume":"317","author":"Nakajima","year":"2018","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.seizure.2019.09.003_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2011.09.054","article-title":"Diabetes GADIatBCN. Association of epilepsy and type 1 diabetes mellitus in children and adolescents: is there an increased risk for diabetic ketoacidosis?","volume":"160","author":"Schober","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.seizure.2019.09.003_bib0035","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s11892-013-0421-9","article-title":"Race\/ethnic difference in diabetes and diabetic complications","volume":"13","author":"Spanakis","year":"2013","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.seizure.2019.09.003_bib0040","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ajhb.22714","article-title":"Meta-analysis of Brazilian genetic admixture and comparison with other Latin America countries","volume":"27","author":"Moura","year":"2015","journal-title":"Am J Hum Biol"},{"key":"10.1016\/j.seizure.2019.09.003_bib0045","doi-asserted-by":"crossref","DOI":"10.1111\/ene.14005","article-title":"Clinical spectrum of glutamic acid decarboxylase antibodies in a Taiwanese population","author":"Kuo","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.seizure.2019.09.003_bib0050","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.20727","article-title":"An association between type 1 diabetes and idiopathic generalized epilepsy","volume":"59","author":"McCorry","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2019.09.003_bib0055","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1528-1167.2009.02380.x","article-title":"Type 1 diabetes and epilepsy: more than a casual association?","volume":"51","author":"Mancardi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.09.003_bib0060","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/jnnp-2015-310512","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with epilepsy and their relationship with type 1 diabetes: a pilot study","volume":"87","author":"Moloney","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2019.09.003_bib0065","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejpn.2018.12.006","article-title":"Epilepsy in children with type 1 diabetes mellitus: pathophysiological basis and clinical hallmarks","volume":"23","author":"Mastrangelo","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2019.09.003_bib0070","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2337\/db12-0696","article-title":"White matter microstructural integrity in youth with type 1 diabetes","volume":"62","author":"Antenor-Dorsey","year":"2013","journal-title":"Diabetes"},{"issue":"2\u20133","key":"10.1016\/j.seizure.2019.09.003_bib0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0920-1211(00)00180-7","article-title":"Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study","volume":"42","author":"Kwan","year":"2000","journal-title":"Epilepsy Res"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131119303966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131119303966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:56:40Z","timestamp":1761011800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131119303966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":15,"alternative-id":["S1059131119303966"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2019.09.003","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between high titers of glutamic acid decarboxylase antibody and epilepsy in patients with type 1 diabetes mellitus: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2019.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}